AURION BIOTECH, INC.

Profile

Company Names

AURION BIOTECH, INC.

Addresses

117 E. LOUISA STREET, #561, SEATTLE, WA 98102

Phone Numbers

206-701-5840

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$26,055,618.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-04-05 
$26,055,618.00 
$26,055,618.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEANNETTE 
 
BANKES 
DIRECTOR
AURION BIOTECH, INC.
ANDREW 
 
ELBARDISSI 
DIRECTOR
NEOCHORD INC   |  CONVENTUS ORTHOPAEDICS INC   |  FARAPULSE, INC.   |  AXON THERAPIES INC.   |  INCARDA THERAPEUTICS, INC.   |  ELEMENT SCIENCE, INC.   |  REPRIEVE CARDIOVASCULAR, INC.   |  NXT BIOMEDICAL, LLC   |  AURION BIOTECH, INC.   |  ACUTUS MEDICAL, INC.   |  ADELA, INC.   |  MEDICAL MICROINSTRUMENTS, INC.
TOM 
 
FRINZI 
DIRECTOR
EYEBRAIN MEDICAL, INC.   |  AURION BIOTECH, INC.   |  CG HOLDING CO.   |  VIALASE, INC.
GREG 
 
KUNST 
EXECUTIVE OFFICER, DIRECTOR
AURION BIOTECH, INC.
ARNAUD 
 
LACOSTE 
EXECUTIVE OFFICER
AURION BIOTECH, INC.
PATRICK 
 
LALLY 
DIRECTOR
BREAZY INC.   |  AURION BIOTECH, INC.   |  CG HOLDING CO.
CHRISTINE 
 
MCCAULEY 
DIRECTOR
AURION BIOTECH, INC.
DAVID 
 
ROSTOV 
EXECUTIVE OFFICER
LIGHTHOUSE DOCUMENT TECHNOLOGIES INC   |  AVALARA INC   |  LIGHTHOUSE HOLDINGS, INC./DE   |  ID METRICS GROUP INC.   |  AURION BIOTECH, INC.
LINK 
 
WILLIAM 
DIRECTOR
AURION BIOTECH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-04-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-05 
2022-04-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-05 
2022-04-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
RAYMOND JAMES
705